Houshmand M, Sanati M-H, Rashedi I, Sharifpanah F, Asghari E, Lotfi J
National Research Center for Genetic Engineering and Biotechnology, Tehran University School of Medicine, Shariati Hospital, #19 Abbass Shafie Alley, Ghods St. Enghelab Avenue, PO Box 14155-6343, Tehran, Iran.
Eur Neurol. 2004;51(2):68-71. doi: 10.1159/000075518. Epub 2003 Dec 10.
The hypothesis that mitochondrial genes may implicate susceptibility to multiple sclerosis (MS) is supported by an increasing number of case reports on Leber's hereditary optic neuropathy (LHON)-associated mitochondrial DNA (mtDNA) point mutations in patients with MS. A number of mtDNA mutations with primary pathogenic significance for LHON, a maternally inherited disease causing severe bilateral visual loss predominantly in young men, have been detected in patients with an MS-like phenotype. To evaluate the link between MS and LHON primary point mutations, we investigated 31 non-related Iranian clinically definite MS patients (23 females and 8 males) with optic nerve involvement, as well as 25 patients (16 females and 9 males) without involvement of the optic nerve as controls. Three patients had severe bilateral visual loss without any recovery. We searched for the presence of LHON mitochondrial mutations at nucleotide positions (np) 11,778, 3,460, and 14,484 by mutation-specific polymerase chain reaction and restriction fragment length polymorphism. Our results suggest that there is no association between Iranian patients with MS and mtDNA point mutations at np 11,778, 3,460, and 14,484.
线粒体基因可能与多发性硬化症(MS)易感性相关的假说,得到了越来越多关于MS患者中与Leber遗传性视神经病变(LHON)相关的线粒体DNA(mtDNA)点突变的病例报告的支持。在具有MS样表型的患者中,已检测到一些对LHON具有主要致病意义的mtDNA突变,LHON是一种主要在年轻男性中导致严重双侧视力丧失的母系遗传疾病。为了评估MS与LHON原发性点突变之间的联系,我们调查了31例有视神经受累的非亲属伊朗临床确诊MS患者(23例女性和8例男性),以及25例无视神经受累的患者(16例女性和9例男性)作为对照。3例患者出现严重双侧视力丧失且无任何恢复。我们通过突变特异性聚合酶链反应和限制性片段长度多态性,搜索了核苷酸位置(np)11778、3460和14484处LHON线粒体突变的存在情况。我们的结果表明,伊朗MS患者与np 11778、3460和14484处的mtDNA点突变之间没有关联。